EuropaBio names Rappagliosi chairman
This article was originally published in Scrip
Executive Summary
EuropaBio, the European association for bioindustries, elected Dr Andrea Rappagliosi chairman at its annual general assembly yesterday in Brussels. He succeeds Steen Riisgaard, president and CEO of Novozymes, and will serve a two-year term.